8
Oct
2024

Icrom SpA

Exhibitor at CPHI Milan 2024 stand 1C26, API
About Us

Italian leading specialist in custom development and contract manufacturing of Active Pharmaceutical Ingredients, ICROM is the boutique outfit for APIs.Leveraging sophisticated know-how, ICROM builds high-tech solutions to create complex molecules and developing flexible, scalable and cost-effective processes, tailored to customers’ needs.With multi-scale capacity in 4 state-of-the-art manufacturing units approved by AIFA, USFDA, PMDA, KFDA, ICROM is the partner of choice for CDMO of NCEs, high-tech generics and your challenge to innovation.

 

Read more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • IT
  • 2015
    On CPHI since
Company types
Manufacturer/Innovator
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 1C26, API

Products Featured at CPHI Milan 2024

  • Alizapride HCl

    Product Alizapride HCl

    Icrom SpA manufactures on commercial base and under full GMP condition a wide range of Active Pharmaceutical Ingredients (APIs) which includes Alizapride HCl. Contact us for more information.
  • Articaine HCl

    Product Articaine HCl

    Icrom SpA is in advanced stage with the development of Articaine HCl. Contact us for more information.
  • Amisulpride

    Product Amisulpride

    Icrom SpA manufactures on commercial base and under full GMP condition a wide range of Active Pharmaceutical Ingredients (APIs) which includes Amisulpride.  CEP certificates is available. Contact us for more information.
  • Bepotastine Besilate

    Product Bepotastine Besilate

    Icrom SpA manufactures on commercial scale and under full GMP condition a wide range of Active Pharmaceutical Ingredients (APIs) which includes Bepotastine Besilate. Contact us for more information.
  • Bortezomib

    Product Bortezomib

    Icrom SpA manufactures on commercial scale and under full GMP condition a wide range of Active Pharmaceutical Ingredients (APIs) which includes Bortezomib. Contact us for more information.